Jennifer L. Good
President & CEO at Trevi Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Trevi Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Trevi Therapeutics Inc. June 11, 202599.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,712 | — | — |
| Jun 18, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,000 | — | — |
| Mar 21, 2025 | Trevi Therapeutics Inc. | Option exercise | +5,263 | $1.43 | $7,526 |
| Mar 21, 2025 | Trevi Therapeutics Inc. | Open-market sale | −5,263 | $6.58 | $34,631 |
| Sep 17, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +15,000 | $22.93 | $343,950 |
| Sep 17, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +9,250 | $21.37 | $197,673 |
| Sep 17, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +7,501 | $18.99 | $142,444 |
| Sep 17, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −31,751 | $52.40 | $1,663,752 |
| Sep 9, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +12,900 | $22.93 | $295,797 |
| Sep 9, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +4,305 | $21.37 | $91,998 |
| Sep 9, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +1,736 | $18.99 | $32,967 |
| Sep 9, 2024 | Trevi Therapeutics Inc. | Option exercise | +1,840 | $1.43 | $2,631 |
| Sep 9, 2024 | Rhythm Pharmaceuticals Inc. | Option exercise | +18,300 | $4.15 | $75,945 |
| Sep 9, 2024 | Trevi Therapeutics Inc. | Open-market sale | −1,840 | $3.04 | $5,594 |
| Sep 9, 2024 | Rhythm Pharmaceuticals Inc. | Open-market sale | −37,241 | $50.45 | $1,878,808 |
Questions about Jennifer L. Good
What boards is Jennifer L. Good on?
Jennifer L. Good sits on the boards of Rhythm Pharmaceuticals Inc. and Trevi Therapeutics Inc.
What company is Jennifer L. Good the CEO of?
Jennifer L. Good is President & CEO of Trevi Therapeutics Inc.
How long has Jennifer L. Good served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.